Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin

IRB/UVA Tracking #
20573
Contact
Contact Phone
Phase
II/III
Primary purpose
Treatment
Cancer PI
Varinder Kaur
Status
OPEN TO ACCRUAL
Ages
Adult